Scott Maxwell

7PUBLICATIONS

29CO-AUTHORS

Major global burdens of diseaseInfant and child healthEpigenetics (incl. genome methylation and epigenomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Traditional Chinese medicine and treatments

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|May 29, 2026

EZH2 inhibition via GSK-126 mitigates EndMT and atherosclerosis in diabetes: A translational epigenetic approach.

|Aug 20, 2025

DNA Methylation Biomarkers Predict Offspring Metabolic Risk From Mothers With Hyperglycemia in Pregnancy.

Johnny Assaf, Ishant Khurana, Ram Abou Zaki

|Apr 17, 2024

Set7 Methyltransferase and Phenotypic Switch in Diabetic Glomerular Endothelial Cells.

Scott Maxwell, Jun Okabe, Harikrishnan Kaipananickal

|Jul 21, 2022

Inhibition of pancreatic EZH2 restores progenitor insulin in T1D donor.

Keith Al-Hasani, Ishant Khurana, Lina Mariana

|Apr 20, 2021

SAHA attenuates Takotsubo-like myocardial injury by targeting an epigenetic Ac/Dc axis.

Ishant Khurana, Scott Maxwell, Simon Royce

|Mar 21, 2021

Epigenetic evidence of an Ac/Dc axis by VPA and SAHA.

Sebastian Lunke, Scott Maxwell, Ishant Khurana

Pageof 2

Frequent Collaborators

Assam El-Osta

Jun Okabe

Keith Al-Hasani

Ishant Khurana

Harikrishnan K N

Tom Karagiannis

Juliana C N Chan

Sebastian Lunke

Simon Royce

Prabhu Mathiyalagan

Frequent Collaborators

Assam El-Osta

Jun Okabe

Keith Al-Hasani

Ishant Khurana